News Check all IrsiCaixa scientific news in just one click. Breadcrumb Home News 06/04/2011 The presence of drug-resistant HIV minority variants doubles the risk of virologic failure in patients 09/03/2011 IrsiCaixa collaborates with the training of researchers in South Africa 07/03/2011 Identification of a group of seropositive patients that can effectively control their infection without medication 25/02/2011 IrsiCaixa holds conferences on the outreach of the research and the prevention of AIDS in Badalona 02/02/2011 Update on therapeutic AIDS vaccine designed by HIVACAT 15/11/2010 HIVACAT draws together international experts in preventive and therapeutic vaccines at the CosmoCaixa Barcelona 05/11/2010 Dr. Bonaventura Clotet, director of IrsiCaixa, winner of the ICS Research Trajectory award 06/10/2010 IrsiCaixa hosts the second meeting of HIVACAT’s Community Advisory Committee 06/09/2010 IrsiCaixa begins to study the XMRV retrovirus, a new retrovirus that could be associated to chronic fatigue and prostate cancer Pagination First Previous … Page 19 Page 20 Page 21 Page 22 Page 23 Page 24 25 Page 26 Page 27 Next Last
06/04/2011 The presence of drug-resistant HIV minority variants doubles the risk of virologic failure in patients
07/03/2011 Identification of a group of seropositive patients that can effectively control their infection without medication
25/02/2011 IrsiCaixa holds conferences on the outreach of the research and the prevention of AIDS in Badalona
15/11/2010 HIVACAT draws together international experts in preventive and therapeutic vaccines at the CosmoCaixa Barcelona
05/11/2010 Dr. Bonaventura Clotet, director of IrsiCaixa, winner of the ICS Research Trajectory award
06/09/2010 IrsiCaixa begins to study the XMRV retrovirus, a new retrovirus that could be associated to chronic fatigue and prostate cancer